Supply report · August 2026 register copy
Antiparasitics in Nigeria: the registration data
Across the 3 antiparasitic molecules Ogbogwu tracks, our August 2026 copy of the NAFDAC Greenbook lists 39 active registrations held by 29 companies — plus 48 registrations recorded as no longer active. Every figure on this page is quoted from that dated copy; the register can change after our copy is taken.
- Active registrations
- 39
- Companies
- 29
- New in the last 12 months
- 1
- Renewals due within a year
- 9
Who holds the registrations
The ten companies with the most active antiparasitic registrations in our copy. The registrant is the NAFDAC applicant of record — for imported lines this is often the Nigerian distributor, not the factory.
- 1.Drugfield Pharmaceuticals— 3 active
- 2.Emzor Pharmaceutical Industries— 3 active
- 3.Fidson Healthcare— 3 active
- 4.GlaxoSmithKline— 2 active
- 5.May & Baker— 2 active
- 6.Shalina Healthcare Nigeria— 2 active
- 7.Swiss Pharma Nigeria— 2 active
- 8.Adpharm Pharmaceutical Industries— 1 active
- 9.Artemis Laboratories— 1 active
- 10.Avro Pharma— 1 active
Where the products are made
Maker country as the register records it, across the 39 active registrations.
- Nigeria— 22 (56%)
- India— 16 (41%)
- China— 1 (3%)
Dosage forms
- Tablet— 22 active
- Suspension— 8 active
- Chewable tablet— 6 active
- Caplet— 2 active
- Capsule— 1 active
Newest registrations
The latest antiparasitic approvals in our copy — 1 products were registered in the twelve months to August 2026.
- Synbate-400 Tablet — B4-9673, approved 2025-09-24
9 active registrations carry expiry dates within the next twelve months. A registration expiry means a renewal is due, not that the product disappears — holders routinely renew — but a lapsed number on a pack is worth checking before a large order. See which ones, by month →
The molecules behind these numbers
- Albendazole — 36 active registrations
- Ivermectin — 2 active registrations
- Praziquantel — 1 active registrations
“Antiparasitics” on this page means these molecules — the register itself has no therapeutic grouping, so a category page must say exactly what it counted.
The most-supplied presentations
- Albendazole 400 mg tablet — 11 companies
- Albendazole 200 mg tablet — 8 companies
- Albendazole 100 mg/5 mL suspension — 5 companies
- Albendazole 400 mg chewable tablet — 4 companies
- Albendazole 200 mg/5 mL suspension — 3 companies
Manufacturing or exporting antiparasitic medicines?
This is the market you'd be entering. See what NAFDAC registration and import into Nigeria require, and talk to us about distribution.
Supply the Nigerian marketOther supply reports
This page quotes the public NAFDAC Greenbook as of our dated copy, across the molecules Ogbogwu tracks in this category. It is a record of registrations, not market-share or sales data, and not an endorsement of any product. Registration status can change; for decisions that matter, confirm on the official Greenbook.